生理代谢MRI氧代谢与新生血管成像鉴别胶质母细胞瘤与孤立性NSCLC脑转移
本研究纳入21例胶质母细胞瘤和27例非小细胞肺癌孤立性脑转移患者，行生理代谢MRI计算氧代谢与新生血管参数，将肿瘤分为五种微环境类型。GBM表现为有氧糖酵解和活性肿瘤比例更高、无新生血管缺氧比例更低；增强区PO2和活性肿瘤百分比鉴别效能最佳（AUC分别为0.911和0.906）。
要点
- 增强区PO2和活性肿瘤百分比鉴别GBM与LBM的AUC分别为0.911和0.906。
- GBM有氧糖酵解比例和活性肿瘤百分比高于LBM，无新生血管缺氧比例低于LBM。
- GBM增强区PO2和MVD更高，水肿区OEF更低。
关键影像表现/征象
- GBM较LBM无新生血管缺氧比例和总缺氧比例更低（q=0.007和0.0035）。
- GBM较LBM有氧糖酵解比例和活性肿瘤百分比更高（q=0.0023和<0.007）。
- GBM水肿区OEF低于LBM（q=0.048）。
诊断标准与关键数值
- 基于OEF、CMRO2、PO2、MVD、VSI、MTI将肿瘤微环境分为坏死、缺氧（伴或不伴新生血管）、氧化磷酸化和有氧糖酵解五型。
- 增强区PO2鉴别GBM与LBM的AUC=0.911。
- 活性肿瘤百分比鉴别GBM与LBM的AUC=0.906。
临床应用与阅片要点
- 可关注增强区PO2和活性肿瘤百分比作为鉴别GBM与LBM的候选定量指标。
- 需结合增强区、坏死区和水肿区的微环境参数综合判读。
局限性
- 样本量较小（GBM 21例、LBM 27例），需多中心大样本验证。
- 研究仅纳入NSCLC来源的孤立性脑转移，需纳入更多转移类型验证。
以上解读依据论文摘要（全文未开放获取或许可不允许翻译转载）。
英文原文（摘要）· 点击展开
PURPOSE: Distinguishing glioblastoma (GBM) from large solitary brain metastases (LBM > 1.5 cm) is crucial for tailoring therapy and optimizing outcomes. We used MRI-derived neovascularization and oxygen metabolism tumor microenvironment (TME) mapping to differentiate GBM from non-small cell lung cancer (NSCLC) origin-LBM.
MATERIAL AND METHODS: This observational study included 21 GBM and 27 LBM patients who underwent physio-metabolic MRI. Imaging parameters related to oxygen metabolism (oxygen extraction fraction [OEF], cerebral metabolic rate of oxygen [CMRO2], tissue oxygen tension [PO2]) and neovascularization (microvessel density [MVD], vessel size index [VSI], microvessel-type indicator [MTI]) were calculated to classify tumors into five TME types: necrosis, hypoxia (with or without neovascularization), oxidative phosphorylation (OxPhos), and aerobic glycolysis. Volume fractions of different TMEs and MRI parameters in enhanced, necrotic, and edematous areas were compared using two-sample t-tests and FDR correction adjusting. Diagnostic performance was evaluated using receiver operating characteristic analysis.
RESULTS: Compared to LBM, GBM showed lower hypoxia without neovascularization and total hypoxia percentage (q = 0.007 and 0.0035, respectively), higher aerobic glycolysis and vital tumor percentage (q = 0.0023 and < 0.007, respectively). In subregions, GBM displayed higher PO2 and MVD value in enhancing area (q = 0.048 and 0,032, respectively). Additionally, GBM exhibited lower OEF in edematous area (q = 0.048) than LBM. Vital tumor percentage and PO2 in enhancing region were the best differentiation markers (AUC = 0.906 and 0.911).
CONCLUSIONS: Physio-metabolic MRI provides noninvasive, quantitative insights into the heterogeneity of tumor microenvironment characteristics, show potential for preoperative discrimination between GBM and LBM. However, larger multicenter validation studies with diverse metastasis types are needed before widely clinical implementation.
引用
- Ou-Yang QH, Pan RT, Yang RH, et al. Physio-metabolic MRI of oxygen metabolism and neovascularization for differentiating glioblastomas from solitary NSCLC brain metastases. Radiol Med. 2026. PMID: 42089903. doi:10.1007/s11547-026-02197-x
供执业医师工作参考，不替代临床判断；数值与分级以指南原文为准。